pillbase.ru

Livmarli

Active substance: maralixibat

TABLET · MARALIXIBAT CHLORIDE 15 mg/1

United StatesActive

Marketing holder: Mirum Pharmaceuticals Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Livmarli
    Maralixibat chloride
    EMEA/H/C/005857
    Mirum Pharmaceuticals International B.V.
  • Livmarli
    Maralixibat chloride
    EMEA/H/C/005551
    FGK Representative Service GmbH
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-32ba-73a0-ae19-a5b887b2aa0b,01a1208c-d642-73d6-88e5-161c08a438ac,01a1208c-d643-76de-9b6f-54c8ae6a13b6,01a12090-ffed-7f94-9ab3-54c0b41990fe,01a12092-cf78-760a-8302-99e2ae609559;count=6 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
79378-215
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 79378-215 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 79378-215 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 79378-215 · Verified 2026-10-09 · open in source